Principal Financial Group
AXDX icon

Principal Financial Group’s Accelerate Diagnostics AXDX Stock Holding History

Principal Financial Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,344
Closed -$253K – 2540
2021
Q3 		$253K Sell
4,344
-214
-5% -$14K ﹤0.01% 2358
2021
Q2 		$367K Buy
4,558
+145
+3% +$11.5K ﹤0.01% 2288
2021
Q1 		$367K Buy
4,413
+330
+8% +$33.5K ﹤0.01% 2221
2020
Q4 		$309K Buy
4,083
+2,962
+264% +$265K ﹤0.01% 2225
2020
Q3 		$119K Sell
1,121
-55
-5% -$7.64K ﹤0.01% 2254
2020
Q2 		$178K Buy
+1,176
New +$116K ﹤0.01% 2201
2018
Q2 		– Sell
-921
Closed -$210K – 2272
2018
Q1 		$210K Buy
921
+92
+11% +$24.2K ﹤0.01% 2097
2017
Q4 		$217K Buy
+829
New +$194K ﹤0.01% 2119

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Principal Financial Group's AXDX Position: Q4 2021 in Review

Principal Financial Group sold out of Accelerate Diagnostics (AXDX) in Q4 2021, closing a stake of 4,344 shares — an estimated $253K sold.

Principal Financial Group first reported a position in AXDX in Q4 2017 and held it in 8 quarters. The position peaked at $367K in Q2 2021. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2021.

  • Principal Financial Group reported no remaining Accelerate Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Principal Financial Group sold 4,344 Accelerate Diagnostics shares in Q4 2021, an estimated $253K.
  • Principal Financial Group first reported a position in Accelerate Diagnostics in Q4 2017 and held it in 8 quarters.
  • Principal Financial Group's Accelerate Diagnostics position peaked at $367K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2021.

Based on Principal Financial Group's 13F filing for Q4 2021, filed 9 Feb 2022.